FDA Cites API Manufacturer Over Inadequate Records and Testing

Drug Industry Daily
A A
The FDA hit API manufacturer Intas Pharmaceuticals over inadequate test records, water quality and other violations.

To View This Article:

Login

Subscribe To Drug Industry Daily